Design, Synthesis, and Biological Evaluation of Triazolyl- and Triazinyl-Quinazolinediones as Potential Antitumor Agents

Figure 1

Different EGFR inhibitors: (a) erlotinib; (b) gefitinib; (c) SQ-I.

(a)

(b)

(c)